These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 28193254)

  • 1. Developing a new diagnostic algorithm for human papilloma virus associated oropharyngeal carcinoma: an investigation of HPV DNA assays.
    Cohen N; Gupta M; Doerwald-Munoz L; Jang D; Young JE; Archibald S; Jackson B; Lee J; Chernesky M
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):11. PubMed ID: 28193254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma.
    Guo M; Khanna A; Dhillon J; Patel SJ; Feng J; Williams MD; Bell DM; Gong Y; Katz RL; Sturgis EM; Staerkel GA
    Cancer Cytopathol; 2014 Feb; 122(2):96-103. PubMed ID: 24339259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification.
    Rohatensky MG; Livingstone DM; Mintchev P; Barnes HK; Nakoneshny SC; Demetrick DJ; Dort JC; van Marle G
    BMC Cancer; 2018 Feb; 18(1):166. PubMed ID: 29422018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
    Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
    Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
    Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
    Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
    Jo VY; Krane JF; Pantanowitz L; Monaco SE
    Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
    Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
    J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus detection in oropharyngeal cancer with gargle samples.
    Imai T; Sato I; Matsumoto K; Asada Y; Kato K; Sogai S; Watanabe K; Sadayasu R; Saijo S; Matsuura K
    B-ENT; 2016; 12(4):263-269. PubMed ID: 29709129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 11. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma.
    Qureishi A; Mawby T; Fraser L; Shah KA; Møller H; Winter S
    Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2675-2683. PubMed ID: 28285422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
    Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of high-risk HPV status of head and neck squamous cell carcinoma using the Roche cobas HPV test on cytologic specimens and acellular supernatant fluid.
    Wright MF; Weiss VL; Lewis JS; Schmitz JE; Ely KA
    Cancer Cytopathol; 2020 Jul; 128(7):482-490. PubMed ID: 32129949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
    Lim MY; Dahlstrom KR; Sturgis EM; Li G
    Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
    Xu B; Ghossein R; Lane J; Lin O; Katabi N
    Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.